Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning

Journal of Hepatology

Volumn 33, Issue 1, 2000, Pages 99-105

  Saeki, Rieko ^a,b   Nagai, Hisaki ^a   Kaneko, Shuichi ^b   Unoura, Masashi ^b   Yamanaka, Naoki ^c   Okamoto, Eiso ^c   Kobayashi, Kenichi ^b   Matsubara, Kenichi ^a,d  

^a OSAKA UNIVERSITY   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Multistep carcinogenesis; Nodule in nodule; RLGS; Tumor heterogeneity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CELL DIFFERENTIATION; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0033918548     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80165-8     Document Type: Article

References (27)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
2. Hamilton SR. Molecular genetics of colorectal carcinoma. Cancer. 70:1992;1216-1221.
3. Vogelstein B, Kinzler KW. The multiple nature of cancer. Trend Genet. 9:1993;138-141.
4. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, et al. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 51:1991;89-93.
5. Walker GJ, Hayward NK, Falvey S, Cooksley WGE. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res. 51:1991;4367-4370.
6. Takahashi K, Kudo J, Ishibashi H, Hirata Y, Niho Y. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology. 17:1993;794-799.
7. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1990;1973-1977.
8. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutation hot spot in the p53 gene in human hepatocellular carcinomas. Nature. 350:1991;427-428.
9. Murakami Y, Hayashi K, Sekiya T. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Res. 51:1991;3356-3361.
10. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res. 52:1992;6358-6364.
11. Popper H. Pathological aspects of cirrhosis. A review. Am J Pathol. 87:1977;228-264.
12. Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K. Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases. Gastroenterology. 91:1986;198-208.
13. Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC. Liver. 7:1987;18-26.
14. Hirohashi S. Pathology and molecular mechanisms of multistage human hepatocarcinogenesis. Harris CC. Multistage Carcinogenesis, 1st ed. 1992;87-93 Japan Sci. Soc. Press, Tokyo.
15. Hirohashi S. Pathology and molecular mechanisms of multistage human hepatocarcinogenesis. Harris CC. Multistage Carcinogenesis, 1st ed. 1992;87-93 CRC Press, Boca Raton.
16. Tsuda H, Hirohashi S, Shimosato Y, Terada M, Hasegawa H. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology. 95:1988;1664-1666.
17. Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci USA. 88:1991;9523-9527.
18. Hirotsune S, Hatada I, Komatsubara H, Nagai H, Kuma K, Kobayakawa K, et al. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res. 52:1992;3642-3647.
19. Nagai H, Hirotsune S, Komatsubara H, Hatada I, Mukai T, Hayashizaki Y, et al. Genomic analysis of human hepatocellular carcinomas using restriction landmark genomic scanning. Cancer Detect Prev. 17:1993;399-404.
20. Nagai H, Ponglikitomongkol M, Mita E, Ohmachi Y, Yoshikawa H, Saeki R, et al. Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-D analysis. Cancer Res. 54:1994;1545-1550.
21. WHO Histological Typing of Tumours of the Liver, Biliary Tract and Pancreas, 2nd ed. Springer-Verlag. 1994.
22. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 7:1954;462-503.
23. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3:1976;2303-2308.
24. Southern EM. Detection of specific sequences among DNA fragments separated by gxel electrophoresis. J Mol Biol. 98:1975;503-507.
25. Tsurimoto T, Fujiyama A, Matsubara K. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci USA. 84:1987;444-448.
26. Nagasue N, Kohno H, Hayashi T, Yamanoi A, Uchida M, Takemoto Y, et al. Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma. Gastroenterology. 105:1993;1449-1454.
27. Oda T, Tsuda H, Sakamoto M, Hirohashi S. Different mutations of the p53 gene in nodule in-nodule hepatocellular carcinoma as an evidence for multistage progression. Cancer Lett. 83:1994;197-200.